NeuLogiq platform earned high marks from ALS and FTD patients using it at home, addressing a gap left by motor-only rating ...
Intelligent Bio Solutions, Inc. ( INBS) announced that it has submitted a 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking clearance for its Intelligent ...
The most damaging LLM flaws rarely stop at an unsafe answer. They cross into retrieval systems, identity controls, tools, ...
Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the submission of ...